Mayo Clinic
Molecular breast imaging scores another victory this time in clinical testing
Submitted by Anonymous on Tue, 2008-12-16 10:23A recent study carried out at the Mayo Clinic in Rochester MN reveals that small breast tumors of less than 2 cm in size can easily be detected by a dual-headed gamma camera set up for molecular breast imaging (MBI). The study is published in the December issue of the American Journal of Roentgenology. Lead author of the study Carrie B. Hruska MD and his colleagues have developed a dual-head MBI system using 2 cadmium zinc telluride detectors to concurrently attain opposing breast views and reduce lesion-to-detector distance.
- Read more
- 1224 reads
Mayo study confirms importance of tamoxifen CYP2D6 testing for breast cancer
Submitted by Anonymous on Fri, 2008-12-12 17:20- alternative therapies
- AstraZeneca
- Breast cancer
- Cancer
- CYP2D6
- Estrogen receptor
- FDA
- Fluoxetine
- fluoxetine
- genotype
- genotyping
- Health
- Health
- healthcare
- Labor
- Labor
- machinery
- Mayo Clinic
- Medicine
- San Antonio
- Selective estrogen receptor modulators
- Selective serotonin reuptake inhibitors
- Sertraline
- Social Issues
- Social Issues
- Tamoxifen
- The Mayo Clinic
- Treatment of bipolar disorder
Mayo Clinic researchers gave a presentation 12/11/08 at the 31st annual San Antonio Breast Cancer Symposium that further confirms the importance of the liver enzyme CYP2D6 in individualizing tamoxifen dosing in breast cancer patients. Tamoxifen is often prescribed to block the effects of estrogen in breast tissue preventing breast cancer recurrence in ER+ (estrogen receptor positive) cancers which require estrogen to grow and spread.
- Read more
- 4121 reads
Mayo Clinic report: Statins ok in rituxan users
Submitted by Anonymous on Tue, 2008-12-09 23:40Mayo Clinic report: Statins ok in rituxan users
- 1101 reads
Risk-adapted strategy shows promise in CLL
Submitted by Anonymous on Sat, 2008-11-15 21:16- Alemtuzumab
- antibodies
- author
- B-cell chronic lymphocytic leukemia
- Blood disorders
- Cancer
- Cancer immunotherapy
- Cancer treatments
- Chemotherapy
- chemotherapy
- Clive Zent
- Entertainment
- Entertainment
- FDA
- Leukemia
- Mayo Clinic
- Medicine
- Monoclonal antibodies
- Oncology
- Person Career
- Rituximab
- Technology
- Technology
Mayo Clinic researchers have published a paper outlining a risk-adapted strategy to treating CLL. This is the first trial asking whether some patients with the disease are better served by taking chemotherapy soon after diagnosis or waiting. CLL is an abbreviation of Chronic Lymphocytic Leukemia. This illness is characterized by an overproduction of white blood cells known as lymphocytes. The disease probably starts out as an abnormal activation of the immune system by some stimulus probably infectious agents.
- Read more
- 1622 reads
Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
Submitted by Anonymous on Mon, 2008-11-03 10:01- Beckman Coulter
- Cancer
- Colonoscopy
- Colorectal cancer
- Diverticulosis
- Fecal occult blood
- Gastroenterology
- Gastrointestinal cancer
- imaging
- Mayo Clinic
- Medical tests
- Medicine
- Minnesota
- Polyp
- Professor
- Rochester
- Stool guaiac test
- Stool tests
- Technology
- Technology
- the Annals of Internal Medicine
- United States
A malignant growth of cells in the large intestine is called colorectal cancer or Rectal Cancer. People over the age of 50 have the higher risk of getting this disease. In the United States this is the fourth most common cause of caner in men and women. Colon cancer develops from the abnormal growths called polyps and can be detected by radiography. If detected early the disease is curable.
- Read more
- 1857 reads
Jury still out on TNF-blocker link to cancer in arthritis patients
Submitted by Anonymous on Fri, 2008-10-31 23:16- American College of Rheumatology's
- Arthritis
- Autoimmune diseases
- Biology
- California
- Cancer
- Eric Matteson
- Immune system
- Immunosuppressants
- Infliximab
- Loreto Carmona
- Madrid
- Mayo Clinic
- Medicine
- Minnesota
- Monoclonal antibodies
- Other
- Rheumatoid arthritis
- Rochester
- the American College
- TNF inhibitor
- Tumor necrosis factor-alpha
- U.S. Food and Drug Administration
Popular rheumatoid arthritis drugs which work by blocking a protein linked with inflammation have been shown to not raise the overall cancer risk according to new information from Spanish researchers released on Saturday. The medication in question known as TNF blockers suppress the immune system through a blockade of activity of an inflammatory protein known as tumor necrosis factor.
- Read more
- 1518 reads
Effectiveness of Probiotics for Irritable Bowel Syndrome
Submitted by Anonymous on Tue, 2008-10-07 10:22- Abdominal pain
- American College of Gastroenterology
- Biology
- Bloating
- Constipation
- Diarrhea
- Functional colonic disease
- Gastroenterology
- Gerald Friedman
- Greg Biancone
- Irritable bowel syndrome
- Jacksonville FL
- Lubiprostone
- Mayo Clinic
- McMaster University
- McMaster University in Ontario
- Medicine
- Montefiore Medical Center
- New York
- New York City
- Ontario
- Orlando
- Other
- Paul Moayyedi
- Placebo
- Probiotic
- Rochester
- Stefano Guandalini
- the American College
- treatment of irritable bowel syndrome
- United States
- University College
The 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando saw several studies presented relating to the efficacy and safety of using probiotics in the treatment of irritable bowel syndrome. Probiotics were found both to alleviate symptoms and help normalize the frequency of bowel movements for patients suffering diarrhea or constipation relating to Irritable Bowel Syndrome (IBS). Dr. Paul Moayyedi and colleagues of several universities undertook a meta-analysis which was then presented at the ACG Annual Scientific meeting in Orlando.
- Read more
- 2270 reads
Bariatric surgery for obesity may improve cardiac risk
Submitted by Anonymous on Thu, 2008-09-25 06:32Patients who are obese have a higher incidence of cardiovascular risk related factors. These have been shown to be improved following bariatric surgery. However it still remains unclear if bariatric surgery lowers the risk of long-standing risk factors for cardiovascular disease. Researchers from the Mayo Clinic in Minnesota performed a methodical study of research that was already published and the cardiovascular risk model utilized in a previously published validation cohort.
- Read more
- 914 reads
Study: MRI not helpful in breast cancer sugery planning
Submitted by Anonymous on Mon, 2008-09-08 08:40A study expected to be unveiled at the American Society of Clinical Oncology Breast Cancer Symposium says that women who receive an MRI after an initial diagnosis of breast cancer are delaying their treatment and are more likely to require a mastectomy rather than some other type of breast conserving surgical intervention. In spite of this very clear evidence regarding the benefits of MRI the authors of the study say that the use of the MRI is definitely on the rise. "There was no rhyme or reason as to when MRIs are being used " said the author of the study Dr. Richard J.
- Read more
- 972 reads
Scoring System can Predict Risk During Cardiac Procedures
Submitted by Anonymous on Thu, 2008-08-28 10:56A newly developed scoring system that will help to assess the patients risk of death after undergoing angioplasty has been confirmed as effective according to the researchers at the Mayo Clinic who were the developers of the new system. The MCRS or the Mayo Clinic Risk Score used just seven very simple and non invasive methods to help them predict the death risk for the patient after undergoing percutaneous coronary intervention which is the most often used method of heart revascularization that is done in the United States today. In 2005 alone US physicians did more than a million PCI's.
- Read more
- 852 reads